Search

Your search keyword '"G. Martini"' showing total 11 results
Start Over Author "G. Martini" Language german
11 results on '"G. Martini"'

2. [Treatment of Sudeck's syndrome with human calcitonin]

Author

R, Nuti, A, Vattimo, V, Turchetti, G, Martini, and G A, Righi

Subjects
Adult, Calcitonin, Male, Time Factors, Diphosphonates, Pain, Technetium, Middle Aged, Technetium Tc 99m Medronate, Whole-Body Counting, Bone and Bones, Reflex Sympathetic Dystrophy, Drug Evaluation, Humans, Female, Radionuclide Imaging, Aged
Abstract

Human calcitonin (Cibacalcin), at a dose of 0.5 mg daily for 15 days followed by 0.5 mg every other day for 4-6 months, was administered to 11 patients (eight men and three women, aged 36-74 years) with posttraumatic reflex sympathetic dystrophy of the lower limbs (stage I-II). Within one month there was significant lessening of pain, improved mobility and less oedema. Biochemical tests were within normal limits before and after treatment, while the pre-treatment raised bone retention of 99mTc-methylene-diphosphonate and increased blood flow in the affected area became normal during treatment. In nine patients healing occurred in the course of four to six months on treatment, in two patients after more than six months. There were no serious side-effects requiring interruption of treatment. These results indicate that human calcitonin should be tried in the treatment of this condition.

Published
1983

7. [Treatment of Sudeck's syndrome with human calcitonin].

Author

Nuti R, Vattimo A, Turchetti V, Martini G, and Righi GA

Subjects
Adult, Aged, Bone and Bones diagnostic imaging, Diphosphonates, Drug Evaluation, Female, Humans, Male, Middle Aged, Pain drug therapy, Radionuclide Imaging, Reflex Sympathetic Dystrophy diagnostic imaging, Reflex Sympathetic Dystrophy metabolism, Technetium, Technetium Tc 99m Medronate, Time Factors, Whole-Body Counting, Calcitonin administration & dosage, Reflex Sympathetic Dystrophy drug therapy
Abstract

Human calcitonin (Cibacalcin), at a dose of 0.5 mg daily for 15 days followed by 0.5 mg every other day for 4-6 months, was administered to 11 patients (eight men and three women, aged 36-74 years) with posttraumatic reflex sympathetic dystrophy of the lower limbs (stage I-II). Within one month there was significant lessening of pain, improved mobility and less oedema. Biochemical tests were within normal limits before and after treatment, while the pre-treatment raised bone retention of 99mTc-methylene-diphosphonate and increased blood flow in the affected area became normal during treatment. In nine patients healing occurred in the course of four to six months on treatment, in two patients after more than six months. There were no serious side-effects requiring interruption of treatment. These results indicate that human calcitonin should be tried in the treatment of this condition.

Published
1983
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results